Download full-text PDF

Source

Publication Analysis

Top Keywords

esophago-gastric 'foam-bezoar'--report
4
'foam-bezoar'--report entity
4
esophago-gastric
1
entity
1

Similar Publications

Background: We elucidated the influence of sarcopenic obesity on postoperative outcomes in patients with oesophago-gastric cancer.

Methods: We conducted a systematic search on MEDLINE, the Cochrane Central Register of Controlled Trials, EMBASE, the World Health Organization International Clinical Trials Platform Search Portal, and ClinicalTrials.gov to identify observational studies published from their inception to September 26, 2024.

View Article and Find Full Text PDF

Background: The aim of this prospective, controlled study was to assess the 5-year follow-up of Laparoscopic Heller-Dor (LHD) in patients with esophago-gastric junction outflow obstruction (EGJOO), compared with achalasia patients (ACH). The management of EGJOO reflects the experience gained with esophageal achalasia, for which LHD has been proven to be an effective long-term treatment. Prospective long-term results of LHD in EGJOO patients are still lacking.

View Article and Find Full Text PDF

The Esophageal Adenocarcinoma Study Group Europe (EACSGE) recently proposed a granular histologic classification of esophageal-esophago-gastric junctional adenocarcinomas (EA-EGJAs) based on the study of naïve surgically resected specimens that, when combined with the pTNM stage, is an efficient indicator of prognosis, molecular events, and response to treatment. In this study, we compared histologic classes of endoscopic biopsies taken before surgical resection with those of the surgical specimen, to evaluate the potential of the EACSGE classification at the initial diagnostic workup. A total of 106 EA-EGJA cases with available endoscopic biopsies and matched surgical resection specimens were retrieved from five Italian institutions.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the presence of therapeutic target molecules in esophagogastric junction (EGJ) and Barrett's adenocarcinomas, focusing on 114 non-Barrett's and 30 Barrett's cases.
  • Various molecular markers were assessed, revealing that a majority of EGJ (81.6%) and Barrett's (86.7%) adenocarcinomas expressed at least one target molecule, with PD-L1 having a significant correlation with better survival rates.
  • The findings suggest that most patients with EGJ and Barrett's adenocarcinoma could benefit from molecular targeted therapy, highlighting the importance of tailored treatments based on individual molecular profiles for improved outcomes.
View Article and Find Full Text PDF

Background: Oesophago-gastric cancer surgery negatively affects quality of life with a high postoperative symptom burden. Several conditions that may be diagnosed and treated after surgery are recognised. However, consensus regarding their definition and management is lacking.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!